Patents by Inventor Marianne Fourtillan

Marianne Fourtillan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal therapeutic system containing valentonin and use thereof as a medicament
    Patent number: 10744122
    Abstract: The invention relates to an adhesive transdermal therapeutic system containing, as an active principle, an association of valentonin (VLT) and 6-methoxyharmalan (6-MH).
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: August 18, 2020
    Inventors: Jean-Bernard Fourtillan, Marianne Fourtillan
  • TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING VALENTONIN AND USE THEREOF AS A MEDICAMENT
    Publication number: 20180000796
    Abstract: The invention relates to an adhesive transdermal therapeutic system containing, as an active principle, an association of valentonin (VLT) and 6-methoxyharmalan (6-MH).
    Type: Application
    Filed: February 4, 2016
    Publication date: January 4, 2018
    Applicant: Soeur Josefa Menendez
    Inventors: Jean-Bernard Fourtillan, Marianne Fourtillan
  • Dihydroimidazo[5.1-a]-beta-carboline derivatives, method for their preparation, and their application as a drug
    Patent number: 7291627
    Abstract: The invention concerns dihydroimidazo[5,1-a]-?-carboline compounds of general formula (I) wherein in particular, R1, R2, R3, R4, R6 and R7, identical or different, independently of one another, present a hydrogen, halogen atom, an alkyl, hydroxyl, alkoxy, trihalogenoalkyl, alkylamino, dialkylamino, aryl, arylalkyl, carboxy, alkylcarbonyloxy, acyl, aryloxy or arylalkoxy group; R5 represents a hydrogen atom, an alkyl or arylalkyl group; and their isomers as well as their addition salts to a pharmaceutically acceptable acid. The inventive compounds are for use in medicine, in particular as hypnotics.
    Type: Grant
    Filed: May 16, 2002
    Date of Patent: November 6, 2007
    Assignee: MACEF
    Inventors: Jean-Bernard Fourtillan, Marianne Fourtillan, Omar Karam, Fabien Zunino, Jean-Claude Jacquesy, Jean-Pierre Tafani
  • Dihydroimidazo[5,1-a]sg(b)-carboline derivatives, method for preparing same and use thereof as medicine
    Publication number: 20060089372
    Abstract: The invention concerns dihydroimi-dazo[5,1-a]-?-carboline compounds of general formula (1), wherein in particular, R1, R2, R2, Ra, R6 and K7, identical or different, independently of one another, represent a hydrogen, halogen atom, an alkyl, hydroxy, alkoxy, trihalogenoalkyl, alkylamino, dialkylamino, aryl, arylalkyl, carboxy, alkylcarbonyloxy, acyl, aryloxy or arylalkoxy group; R3 represents a hydrogen atom, an alkyl or arylalkoxy group; and their isomers as well as their addition salts to a pharmaceutically acceptable acid. The inventive compounds arm for use as medicine, in particular as hypnotic.
    Type: Application
    Filed: May 16, 2002
    Publication date: April 27, 2006
    Inventors: Jean-Bernard Fourtillan, Marianne Fourtillan, Omar Karam, Fabien Zunino, Jean-Claude Jacquesy, Jean-Pierre Tafani
  • Pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament
    Patent number: 6335346
    Abstract: The invention relates to pyrrolo[3,4-b]quinoline derivatives of general formula (I) wherein X represents an oxygen atom or a sulphur atom. Said derivatives have a hypnotic or sedative effect.
    Type: Grant
    Filed: December 26, 2000
    Date of Patent: January 1, 2002
    Assignees: MACEF, Laboratoires Besins Iscovesco
    Inventors: Jean-Bernard Fourtillan, Marianne Fourtillan, Jean-Claude Jacquesy, Omar Karam, Fabien Zunino, Marie-Paule Jouannetaud
  • Acyl derivatives of melatonin and of melatoninergic analogues and their use as medicinal products
    Patent number: 6140372
    Abstract: The invention relates to derivatives of general formula I ##STR1## as defined in the description. The invention also relates to a process for their preparation and to their therapeutic use, in particular for the treatment of complaints associated with melatonin disorders, and pharmaceutical and cosmetic compositions comprising them.
    Type: Grant
    Filed: April 16, 1999
    Date of Patent: October 31, 2000
    Assignee: Cemaf and Laboratories Besins Isovesco S.A.
    Inventors: Jean-Bernard Fourtillan, Marianne Fourtillan, Jean-Claude Jacquesy, Marie-Paule Jouannetaud, Bruno Violeau, Omar Karam
  • Oxidation derivatives of indolylalkylamines and their use as drugs
    Patent number: 6066663
    Abstract: The invention relates to derivatives of general formula I ##STR1## The invention also relates to pharmaceutical and cosmetic compositions comprising derivatives of general formula I.
    Type: Grant
    Filed: August 11, 1998
    Date of Patent: May 23, 2000
    Assignees: CEMAF, Laboratories Besins-Iscovesco S.A.
    Inventors: Jean-Bernard Fourtillan, Marianne Fourtillan, Jean-Claude Jacquesy, Marie-Paule Jouannetaud, Bruno Violeau, Omar Karam
  • Melatonin-antagonist .beta.-carboline derivatives and analogues thereof containing naphthalenic structure, process for their preparation and their use as medicinal products
    Patent number: 6048868
    Abstract: The present invention provides .beta.-carboline derivatives useful as components of cosmetic, medicinal, and pharmaceutical compositions. The medicinal and pharmaceutical compositions can be used to induce hypnotic activity in a subject. Methods of producing the .beta.-carboline derivatives are provided as well.
    Type: Grant
    Filed: March 17, 1998
    Date of Patent: April 11, 2000
    Assignees: Cemaf, Laboratories Besins Iscovesco
    Inventors: J-Bernard Fourtillan, Marianne Fourtillan, Jean-Claude Jacquesy, Marie-Paule Jouannetaud, Bruno Violeau, Omar Karam
  • Acylated derivatives of melationin and its analogues, useful as medicaments
    Patent number: 6004991
    Abstract: The invention relates to derivatives of general formula I ##STR1## as defined in the description. The invention also relates to a process for their preparation and to their therapeutic use, in particular or the treatment of complaints associated with melatonin disorders, and pharmaceutical and cosmetic compositions comprising them.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: December 21, 1999
    Assignee: CEMAF and Laboratoires Besins Iscovesco S.A.
    Inventors: Jean-Bernard Fourtillan, Marianne Fourtillan, Jean-Claude Jacquesy, Marie-Paule Jouannetaud, Bruno Violeau, Omar Karam
  • Melatoninergic agonist spiro ?indolepyrrolidine! derivatives, process for their preparation and their use as medicinal products
    Patent number: 5763471
    Abstract: The present invention relates to spiro?3H-indole-3(2H),3'-pyrrolidine! derivatives of general formula I ##STR1## as defined in the description. The invention also relates to a process for their preparation and to their therapeutic use, in particular for the treatment of complaints associated with melatonin disorders, and to the pharmaceutical and cosmetic compositions comprising them.
    Type: Grant
    Filed: December 11, 1996
    Date of Patent: June 9, 1998
    Assignees: CEMAF, Laboratories Besins Iscovesco
    Inventors: Jean-Bernard Fourtillan, Marianne Fourtillan, Jean-Claude Jacquesy, Marie-Paule Jouannetaud, Bruno Violeau, Omar Karam